Lenvatinib as a therapy for unresectable hepatocellular carcinoma
Author:
Affiliation:
1. Division of Oncology, University Hospital of Modena, Modena, Italy
Funder
not funded
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2018.1524297
Reference40 articles.
1. Cancer statistics, 2017
2. Epidemiology of Viral Hepatitis and Hepatocellular Carcinoma
3. Alcohol and hepatocellular carcinoma
4. Long-term Effects of Hepatitis B Immunization of Infants in Preventing Liver Cancer
5. Eradication of Hepatitis C Virus Infection and the Development of Hepatocellular Carcinoma
Cited by 28 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Small-molecule-based targeted therapy in liver cancer;Molecular Therapy;2024-08
2. A New polymorphic forms of Lenvatinib mesylate and process for their preparation;Indian Journal of Chemistry;2024-05-22
3. Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response;Cancers;2024-02-13
4. Comparison of Efficacy and Safety of Anti-Programmed Cell Death-1 Antibody Plus Lenvatinib and Chemotherapy as First-Line Therapy for Patients with Stage IV Gallbladder Cancer: A Real-World Study in a Chinese Population;Biomedicines;2023-10-30
5. Multi-region sampling with paired sample sequencing analyses reveals sub-groups of patients with novel patient-specific dysregulation in Hepatocellular Carcinoma;BMC Cancer;2023-02-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3